New Delhi: Iyadoo laga jawaabayo soo jeedin ka timid Fresenius Medical Care, Guddiga Khabiirada Gaarka ah (SEC) ee Ururka Xakamaynta Heerarka Daawooyinka Dhexe (CDSCO) ayaa ku taliyay in shirkaddu ay soo gudbiso sababta oggolaanshaha oo ay weheliso xogta tijaabada caafimaad ee wejiga III ee kalsiyum chloride dihydrate iyo xogta kormeerka suuqgeynta kadib ee ka timid waddamada la ansixiyay si loo sii tixgeliyo.
Shirkaddu waxay hore u gudbisay codsi ah inay soo saarto oo ay suuq geyso xalka kaalshiyamka chloride dihydrate oo ah 100 mmol/L, kaas oo loo isticmaalo "daaweynta beddelka kaalshiyamka ee daaweynta beddelka kelyaha ee joogtada ah (CRRT), dialysis-ka waxtarka hooseeya (maalinle) ee joogtada ah (CLED) iyo is-weydaarsiga plasma-ga daaweynta (TPE) oo leh citrate anti xinjirowga. Badeecadu waxay ku habboon tahay dadka waaweyn iyo carruurta" waxayna sheegtay sababaha looga saaray tijaabooyinka kiliinikada ee wejiga III iyo wejiga IV.
Guddiga ayaa xusay in badeecadan laga ansixiyay wadamada Yurub sida Portugal, United Kingdom, Brazil, Switzerland, France iyo Denmark.
Isku-darka kaalshiyamka chloride dihydrate waa CaCl2 2H2O, kaas oo ah kaalshiyam chloride oo ka kooban laba molecules oo biyo ah halkii cutub ee kaalshiyam chloride. Waa walax cad oo crystalline ah, oo si fudud ugu milmi karta biyaha oo hygroscopic ah, tusaale ahaan awood u leh inay nuugto qoyaanka hawada.
Kaalshiyam chloride dihydrate waa isku-dhis loo isticmaali karo nidaam dareere ah si loo milmo chitin marka lagu milmo methanol. Waxay door muhiim ah ka ciyaartaa jebinta qaab-dhismeedka kiristaalka ee chitin waxayna leedahay adeegyo badan oo ku saabsan cilmiga kiimikada.
Kulankii SEC Nephrology ee la qabtay Maajo 20, 2025, guddigu wuxuu dib u eegay soo jeedin lagu ansixiyay soo saarista iyo suuqgeynta xalka 100 mmol/L ee kaalshiyamka chloride dihydrate si loogu isticmaalo "daaweynta beddelka kaalshiyamka ee daaweynta beddelka kelyaha ee joogtada ah (CRRT), dialysis-ka waxtarka hooseeya (maalinle ah) ee joogtada ah (SLEDD), iyo is-weydaarsiga plasma-ga daaweynta (TPE) oo leh citrate anti xinjirowga. Badeecada waxaa lagu tilmaamay dadka waaweyn iyo carruurta" waxayna bixisay cudurdaar ka-dhaafitaan tijaabooyinka kiliinikada ee wejiga III iyo IV.
Ka dib markii si faahfaahsan looga dooday, guddigu wuxuu soo jeediyay in aasaaska ansixinta, iyo sidoo kale xogta tijaabada caafimaad ee wejiga saddexaad iyo xogta la socodka suuqgeynta kadib ee ka timid waddamada ansixiyay daawada, loo gudbiyo guddiga si loo sii tixgeliyo.
Sidoo kale akhri: Kooxda CDSCO waxay ansixisay Calaamadaynta la cusbooneysiiyay ee Myozyme-ka Sanofi, waxayna codsatay dib u eegis sharciyeed
Dr. Divya Kolin waa qalinjabiye ka qalinjabisay PharmD oo leh khibrad ballaaran oo caafimaad iyo isbitaal iyo xirfado baaritaan iyo daaweyn oo heer sare ah. Waxay sidoo kale ka shaqeysay farmashiistaha kansarka ee waaxda kansarka ee Kulliyadda Caafimaadka iyo Machadka Cilmi-baarista ee Mysore. Waxay hadda ku raad joogtaa shaqadeeda cilmi-baarista caafimaadka iyo maareynta xogta kiliinikada. Waxay la shaqeyneysay Wadahadalka Caafimaadka tan iyo Janaayo 2022.
       Dr Kamal Kant Kohli, MBBS, MD, CP, is a thoracic specialist with over 30 years of experience and specializes in clinical writing. He joins Medical Dialogues as the Editor-in-Chief of Medical News. Apart from writing articles, as the Editor, he is responsible for proofreading and reviewing all medical content published in Medical Dialogues, including content from journals, research papers, medical conferences, guidelines, etc. Email: drkohli@medicaldialogues.in Contact: 011-43720751
Daraasadda ABYSS waxay ogaatay in joojinta beta-blockers ka dib wadne xanuunka wadnaha ay keentay kororka cadaadiska dhiigga, garaaca wadnaha, iyo dhacdooyinka xun ee wadnaha iyo xididdada dhiigga: ...